Leila Karimi, MD, PhD

Director of Real-World Evidence
Cytel, Netherlands

Poster(s):

• (A-102) Addressing methodological challenges in estimating treatment effects using external controls in rare disease clinical trials when controls cross over to open label treatment
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET